
Multiple myeloma death rates are declining as targeted therapies and immunotherapy improve survival, offering patients longer lives and more treatment options.

Multiple myeloma death rates are declining as targeted therapies and immunotherapy improve survival, offering patients longer lives and more treatment options.

Roger Klinger shares his powerful journey surviving esophageal cancer and ARVC while caring for his husband, finding hope through community and love.

Dr. Aneel Damle explains colorectal cancer staging, treatment options, minimally invasive surgery and personalized care to help improve patient outcomes.

A three-time cancer survivor shares her journey with Lynch Syndrome and her transition from patient to advocate through a Lynch Syndrome vaccine trial.

Learn about rare phyllodes tumors, from benign to malignant grades, including surgical options, recovery and key questions for your oncology team.

Dr. Tony Anderson discusses balancing cancer treatment timing with fertility preservation and the ethical importance of long-term planning for stored gametes.

A patient facing brain surgery finds comfort in "Grey's Anatomy" tropes and a surprise hospital dinner provided by her boyfriend's local restaurant.

A patient details diagnosis, transplant treatment and the complex path to recovery and survivorship after leukemia.

Following FDA approval, Veppanu (vepdegestrant) provides a new oral treatment option for patients with ESR1-mutated, ER+/HER2- metastatic breast cancer.

Summer, with its promise of warmth and freedom, can present unexpected challenges for breast cancer survivors navigating life after a mastectomy.

New AHN research shows high-intensity resistance training is safe and essential for breast cancer survivors to gain strength and functional mobility.

New therapies are beginning to crack KRAS, offering tumor shrinkage and longer survival as researchers work to overcome resistance.

Elrexfio improved progression-free survival in multiple myeloma, helping patients live longer without disease worsening in a phase 3 trial.

Transitioning from active cancer treatment brings a new kind of uncertainty. Learn how to navigate life when the medical guardrails are removed.

Dr. David Greenberg outlines bladder cancer staging, BCG, immunotherapy, surgery, quality of life impacts and long-term follow-up care strategies.

Dr. Ramy Sedhom highlights screening and care pathways that improve outcomes and strengthen psychosocial support for patients with cancer.

Diagnosed with both AIDS and cancer, a writer finds solace in the Cape May surf and the profound gift of a friend truly engaging with his life’s work.

KRAS was long thought undruggable in cancer until scientists discovered a hidden binding pocket in mutant KRAS, leading to targeted therapies.

New immunotherapy use before and after surgery improves outcomes, making early symptom recognition and expert care more critical than ever.

Dr. Ramy Sedhom discusses how embedded psychosocial care in oncology may improve access, engagement and emotional support during cancer care.

Urologist Dr. Susan MacDonald breaks down the differences between soft tissue and blood cancers while highlighting common and rare disease types.

Phase 3 trial shows Datroway significantly extended overall and progression-free survival in patients with previously untreated, advanced TNBC ineligible for immunotherapy.

MD Anderson’s Dr. Wendy Woodward discusses breath-hold techniques, insurance hurdles, and proton therapy’s role in reducing radiation cardiac toxicity.

Dr. Tony Anderson speaks about fertility preservation options for men and women before cancer treatment, emphasizing early testing and timely referral.

A healthcare provider shares her journey with multiple myeloma, discussing the physical, emotional and financial challenges of living with cancer.

Colorectal cancer is rising in younger adults. Dr. Jeremy Kortmansky, discusses causes, symptoms, screening barriers, and prevention.

FDA reviews Ziihera combinations for HER2-positive gastroesophageal cancer, showing potential benefit as a first-line treatment option for patients.

Dr. Nguyen shares how breast cancer patients in rural areas can overcome travel barriers and confidently discuss clinical trials with their doctors.

Learn why timing and muscle health are vital when using GLP-1 therapy for weight management during and after breast cancer treatment.

Dr. Tony Anderson discusses key questions after a cancer diagnosis and fertility planning.